MTOR and Miyoshi myopathy: Pre treating MM cells with U0126 (Mek1/2 inhibitor) followed by MK-2206 treatment demonstrated synergy in killing MM cells and our results clearly indicated that the drug combination inhibited mTOR activity significantly.